Floatz logo

Rapamycin

Tuberous Sclerosis Complex

Children's Hospital Medical Center, CincinnatiPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Tuberous Sclerosis Complex cohort.

Asset / SponsorPhaseRating
Everolimus
Hospices Civils de Lyon
Phase 3BBB
Rapamycin
Katarzyna Kotulska
Phase 3BBB
NPC-12G
Nobelpharma
Phase 3BB
Carbamazepine
GRIN Therapeutics, Inc.
Phase 3BB
Ganaxolone
Marinus Pharmaceuticals
Phase 3BB

View all 23 →

Same molecule, other indications

Rapamycin is also rated in:

tuberous sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
disease related to transplantationDormant
BBB
Indicative ·
72 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →